Psychiatry and Neurology, Neurology · Kansas City, KS
NPI
1124446406
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
Kansas University Medical Center Department, 3599 Rainbow Blvd., Mailstop 2012
Kansas City, KS, 66160
Phone (913) 588-6970
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
532 services
Medicare patients, 2024
192
Average age 65
Drug cost, 2024
$4.5M
2,363 prescriptions
Company payments, 2025
$235
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda J Thuringer was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 167 times for 121 patients. In total Amanda J Thuringer billed 532 services in 19 codes, and Medicare paid $29K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 167 | 121 | $11.86 | $1,980 |
| 99214 Office E&M - Established | Office | 104 | 87 | $65.07 | $6,767 |
| 99215 Office E&M - Established | Office | 96 | 80 | $103.97 | $9,981 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 36 | 18 | $23.39 | $842 |
| 99205 Office E&M - New | Office | 24 | 24 | $140.01 | $3,360 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 13 | $60.75 | $1,094 |
| 99213 Office E&M - Established | Office | 13 | 12 | $50.72 | $659 |
By year: 2022 $32K for 413 services; 2023 $29K for 406 services; 2024 $29K for 532 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amanda J Thuringer prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 240 prescriptions and refills. In total Amanda J Thuringer wrote 2,363 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 240 | 302 | 32 | $44K |
| Baclofen Generic | 193 | 353 | 52 | $5,257 |
| Gabapentin Generic | 160 | 295 | 42 | $4,137 |
| Kesimpta Pen Ofatumumab | 111 | 123 | 11 | $1.0M |
| Pregabalin Generic | 79 | 87 | 16 | $1,392 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 75 | 75 | Under 11 | $549K |
| Glatiramer Acetate Generic | 74 | 74 | Under 11 | $167K |
| Levetiracetam Generic | 62 | 99 | Under 11 | $1,255 |
| Dimethyl Fumarate Generic | 59 | 67 | Under 11 | $42K |
| Duloxetine Hcl Generic | 54 | 123 | 15 | $1,187 |
| Modafinil Generic | 51 | 74 | Under 11 | $9,252 |
| Teriflunomide Generic | 47 | 47 | Under 11 | $20K |
| Methotrexate Methotrexate Sodium | 46 | 93 | Under 11 | $664 |
| Vumerity Diroximel Fumarate | 38 | 38 | Under 11 | $302K |
| Tizanidine Hcl Generic | 36 | 60 | Under 11 | $431 |
Brand drugs: 533 claims; generic drugs: 1,830 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda J Thuringer $235 ($235 in general payments such as food, travel and fees) from 4 companies. The largest payer was Vanda Pharmaceuticals Inc. with $94.91.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.